Q&A: Survey supports OTC progestin-only pill availability to increase contraceptive access

In the NewsArticle

Dec 8

Written By Free the Pill

Kate Grindlay, Ibis Reproductive Health and Free the Pill research consultant, spoke with Healio about findings from the Adherence with Continuous-Dose Oral Contraceptive: Evaluation of Self-Selection and Use (ACCESS) study.

barrierscontraceptive useFDAOTC accessprogestin-only pillssafety and efficacyyoung people

Free the Pill

It's time for birth control pills to move over the counter

More data emerge on progestin-only birth control, as FDA mulls OTC switch